NCI News Releases
31 January 2023
The latest cancer news from the U.S. government's principal agency for cancer research.-
NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
-
Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health
A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.
-
Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Overall cancer death rates continued to fall among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.
Feed not found.
